These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38173558)

  • 21. Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.
    Oczkowska A; Florczak-Wyspianska J; Permoda-Osip A; Owecki M; Lianeri M; Kozubski W; Dorszewska J
    Curr Genomics; 2015 Aug; 16(4):215-23. PubMed ID: 27006626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
    Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
    Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and molecular genetic findings of hereditary Parkinson's patients from Turkey.
    Emekli I; Tepgeç F; Samancı B; Toksoy G; Hasanoğulları Kına G; Tüfekçioğlu Z; Başaran S; Bilgiç B; Gürvit IH; Emre M; Uyguner ZO; Hanagasi HA
    Parkinsonism Relat Disord; 2021 Dec; 93():35-39. PubMed ID: 34781237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder.
    Mufti K; Rudakou U; Yu E; Krohn L; Ruskey JA; Asayesh F; Laurent SB; Spiegelman D; Arnulf I; Hu MTM; Montplaisir JY; Gagnon JF; Desautels A; Dauvilliers Y; Gigli GL; Valente M; Janes F; Högl B; Stefani A; Holzknecht E; Šonka K; Kemlink D; Oertel W; Janzen A; Plazzi G; Antelmi E; Figorilli M; Puligheddu M; Mollenhauer B; Trenkwalder C; Sixel-Döring F; Cochen De Cock V; Monaca CC; Heidbreder A; Ferini-Strambi L; Dijkstra F; Viaene M; Abril B; Boeve BF; Postuma RB; Rouleau GA; Gan-Or Z
    Mov Disord; 2021 Jan; 36(1):235-240. PubMed ID: 33001463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A glimpse of the genetics of young-onset Parkinson's disease in Central Asia.
    Kaiyrzhanov R; Aitkulova A; Vandrovcova J; Murphy D; Zharkinbekova N; Shashkin C; Akhmetzhanov V; Kaishibayeva G; Karimova A; Myrzayev Z; Murray M; Khaibullin T; Hardy J; Houlden H
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1671. PubMed ID: 33818904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of Parkinson's disease--state of the art, 2013.
    Bonifati V
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S23-8. PubMed ID: 24262182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    van der Merwe C; Carr J; Glanzmann B; Bardien S
    Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study.
    Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N
    Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease.
    Huttenlocher J; Stefansson H; Steinberg S; Helgadottir HT; Sveinbjörnsdóttir S; Riess O; Bauer P; Stefansson K
    Hum Mol Genet; 2015 Oct; 24(19):5637-43. PubMed ID: 26188007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of cognitive dysfunction in Parkinson's disease.
    Wise AH; Alcalay RN
    Prog Brain Res; 2022; 269(1):195-226. PubMed ID: 35248195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease.
    Ton ND; Thuan ND; Thuong MTH; Ngoc TTB; Nhung VP; Hoa NTT; Nam NH; Dung HT; Son ND; Ba NV; Bac ND; Tai TN; Dung LTK; Hung NT; Duong NT; Ha NH; Hai NV
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1463. PubMed ID: 32856414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging genetic diversity to understand monogenic Parkinson's disease's landscape in AfrAbia.
    Mohamed W
    Am J Neurodegener Dis; 2023; 12(4):108-122. PubMed ID: 37736165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of Parkinson's disease in the Polish population.
    Milanowski ŁM; Ross OA; Friedman A; Hoffman-Zacharska D; Gorka-Skoczylas P; Jurek M; Koziorowski D; Wszolek ZK
    Neurol Neurochir Pol; 2021; 55(3):241-252. PubMed ID: 33539026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.
    Pachchek S; Landoulsi Z; Pavelka L; Schulte C; Buena-Atienza E; Gross C; Hauser AK; Reddy Bobbili D; Casadei N; May P; Krüger R;
    NPJ Parkinsons Dis; 2023 Nov; 9(1):156. PubMed ID: 37996455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort.
    Usnich T; Vollstedt EJ; Schell N; Skrahina V; Bogdanovic X; Gaber H; Förster TM; Heuer A; Koleva-Alazeh N; Csoti I; Basak AN; Ertan S; Genc G; Bauer P; Lohmann K; Grünewald A; Schymanski EL; Trinh J; Schaake S; Berg D; Gruber D; Isaacson SH; Kühn AA; Mollenhauer B; Pedrosa DJ; Reetz K; Sammler EM; Valente EM; Valzania F; Volkmann J; Zittel S; Brüggemann N; Kasten M; Rolfs A; Klein C;
    Front Neurol; 2021; 12():710572. PubMed ID: 34475849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.